+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Obesity Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • PDF Icon


  • 197 Pages
  • February 2024
  • Infogence Global Research
  • ID: 5748876

Market is embracing AI-powered digital health platforms and non-invasive procedures to provide holistic weight management solutions.

The Global Obesity Treatment Market is estimated to be USD 17.01 Bn in 2023 and is expected to reach USD 27.21 Bn by 2028 growing at a CAGR of 9.85%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Obesity Treatment Market is segmented based on Treatment and Geography.
  • By Treatment, the market is classified into Drugs and Surgery.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Obesity Treatment Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Obesity Treatment Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Obesity Treatment Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Unhealthy and Sedentary Lifestyle
4.1.2 Growing Number of Obese Populace Coupled with Prevalence of Chronic Diseases
4.2 Restraints
4.2.1 Strict Product Approval Rules
4.3 Opportunities
4.3.1 Increasing Healthcare Expenditures
4.3.2 Research and Development of the Obesity Treatment
4.4 Challenges
4.4.1 Risks of Probable Side Effects Varying Between Individuals
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Obesity Treatment Market, By Treatment
6.1 Introduction
6.2 Drugs
6.2.1 Appetite Suppressants
6.2.2 Combination Drugs
6.2.3 Malabsorption & Satiety Drugs
6.3 Surgery
6.3.1 Adjustable Gastric Banding
6.3.2 Biliopancreatic Diversion with Duodenal Switch
6.3.3 Endoscopic Procedures
6.3.4 Roux-en-Y Gastric Bypass
7 Americas' Obesity Treatment Market
7.1 Introduction
7.2 Argentina
7.3 Brazil
7.4 Canada
7.5 Chile
7.6 Colombia
7.7 Mexico
7.8 Peru
7.9 United States
7.10 Rest of Americas
8 Europe's Obesity Treatment Market
8.1 Introduction
8.2 Austria
8.3 Belgium
8.4 Denmark
8.5 Finland
8.6 France
8.7 Germany
8.8 Italy
8.9 Netherlands
8.10 Norway
8.11 Poland
8.12 Russia
8.13 Spain
8.14 Sweden
8.15 Switzerland
8.16 United Kingdom
8.17 Rest of Europe
9 Middle East and Africa's Obesity Treatment Market
9.1 Introduction
9.2 Egypt
9.3 Israel
9.4 Qatar
9.5 Saudi Arabia
9.6 South Africa
9.7 United Arab Emirates
9.8 Rest of MEA
10 APAC's Obesity Treatment Market
10.1 Introduction
10.2 Australia
10.3 Bangladesh
10.4 China
10.5 India
10.6 Indonesia
10.7 Japan
10.8 Malaysia
10.9 Philippines
10.10 Singapore
10.11 South Korea
10.12 Sri Lanka
10.13 Thailand
10.14 Taiwan
10.15 Rest of Asia-Pacific
11 Competitive Landscape
11.1 Competitive Quadrant
11.2 Market Share Analysis
11.3 Strategic Initiatives
11.3.1 M&A and Investments
11.3.2 Partnerships and Collaborations
11.3.3 Product Developments and Improvements
12 Company Profiles
12.1 AbbVie Inc.
12.2 Apollo Endosurgery, Inc.
12.3 Atkins Nutritional's, Inc.
12.4 BTL Aesthetics
12.5 C.H. Boehringer Sohn AG & Co. KG
12.6 Currax Pharmaceuticals LLC
12.7 F. Hoffmann-La Roche, Ltd.
12.8 Herbalife Ltd.
12.9 Johnson & Johnson
12.10 Kellogg Co.
12.11 Mediflex Surgical Products
12.12 Medtronic PLC
12.13 Novo Nordisk A/S
12.14 NutriSystem, Inc.
12.15 Olympus Corp.
12.16 Pfizer, Inc.
12.17 Takeda Pharmaceuticals, Inc.
12.18 Technogym S.p.A
12.19 USGI Medical, Inc.
12.20 Vivus, Inc.
13 Appendix
13.1 Questionnaire

Companies Mentioned

  • AbbVie Inc.
  • Apollo Endosurgery, Inc.
  • Atkins Nutritional's, Inc.
  • BTL Aesthetics
  • C.H. Boehringer Sohn AG & Co. KG
  • Currax Pharmaceuticals LLC
  • F. Hoffmann-La Roche, Ltd.
  • Herbalife Ltd.
  • Johnson & Johnson
  • Kellogg Co.
  • Mediflex Surgical Products
  • Medtronic PLC
  • Novo Nordisk A/S
  • NutriSystem, Inc.
  • Olympus Corp.
  • Pfizer, Inc.
  • Takeda Pharmaceuticals, Inc.
  • Technogym S.p.A
  • USGI Medical, Inc.
  • Vivus, Inc.